Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
LLY Expands Cell Therapy Ambitions With $2.4B Orna Therapeutics Deal
12:10pm, Tuesday, 10'th Feb 2026
Eli Lilly is set to buy Orna Therapeutics for $2.4B to expand in vivo CAR-T and circular RNA capabilities, signaling a long-term push to diversify its pipeline.
Novo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment?
02:30pm, Monday, 09'th Feb 2026
Eli Lilly has been a growth beast and its top line may soar by as much as 27% this year. Novo Nordisk is bracing for a potential double-digit decline in sales, as it tries to fight off copycat version
Jefferies Group Exits Vanguard Information Technology ETF, Impacting Portfolio by -8.06%
01:00pm, Monday, 09'th Feb 2026
Jefferies Group (Trades, Portfolio)'s Strategic Moves in Q4 2025: A Detailed Analysis Jefferies Group (Trades, Portfolio) recently submitted its 13F filing for
Unlocking Lilly (LLY) International Revenues: Trends, Surprises, and Prospects
10:16am, Monday, 09'th Feb 2026
Explore how Lilly's (LLY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:00am, Monday, 09'th Feb 2026
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
3 Safety-First ETFs to Retire in Comfort
09:22am, Monday, 09'th Feb 2026
When you're in or near your retirement years and safety becomes priority number one, picking out individual stocks can seem risky. As an alternative to single stocks, you can own exchange traded funds
Eli Lilly Bets $2.4 Billion On Small Biotech To Boost Future Cell Treatments
09:11am, Monday, 09'th Feb 2026
The strategic move is seen as a significant step in enhancing Lilly's capabilities in genetic medicine, adding pressure as broader markets edged lower.
Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion
08:37am, Monday, 09'th Feb 2026
Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash.
2 stocks to hit $1 trillion market cap in Q1 2026
07:55am, Monday, 09'th Feb 2026
As equity markets move deeper into 2026, more stocks are showing potential to join the $1 trillion club despite recent volatility.
Eli Lilly Pays $350 Million Upfront in China Biotech Collaboration Deal
07:29am, Monday, 09'th Feb 2026
Eli Lilly (LLY) has agreed to pay $350 million upfront to partner with Innovent Biologics on the joint development of new therapies targeting cancer and immune
Eli Lilly Stock Rises. It's Acquiring This Cell Therapy Company for $2.4 Billion.
07:18am, Monday, 09'th Feb 2026
Lilly agrees to acquire Orna Therapeutics in an all-cash deal.
Lilly to buy Orna Therapeutics for up to $2.4 billion
07:06am, Monday, 09'th Feb 2026
Eli Lilly will acquire therapy developer Orna Therapeutics for up to $2.4 billion in cash, the companies said on Monday.
Lilly to acquire Orna Therapeutics to advance cell therapies
07:00am, Monday, 09'th Feb 2026
Orna's in vivo CAR-T pipeline includes potential best-in-class programs to reset the immune system and address B cell-driven autoimmune diseases Acquisition provides a broad platform for long-term inn
Innovent Biologics Strikes Partnership Deal With Eli Lilly
12:57am, Monday, 09'th Feb 2026
Chinese drugmaker Innovent Biologics and Eli Lilly plan to target cancer and immune system diseases under the partnership.
3 Things Investors Need to Know About the Healthcare Sector in 2026
09:13am, Saturday, 07'th Feb 2026
Healthcare stocks are, on average, slightly cheaper than other kinds of stocks. That doesn't mean they're less risky to buy at the moment.
